The nation of Zimbabwe has declined a significant American health deal valued at $367m (272 million pounds) over five years because of Washington's demand for confidential biological samples.
This move came to light after a official document from December was leaked, indicating that President Emmerson Mnangagwa felt the deal was "unbalanced".
An official representative has since explained that the United States was requesting biological samples for research and commercial purposes while refused to guarantee the resulting advantages from future vaccines.
"We will now turn to the difficult and regrettable task of scaling back our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the US had donated over $1.9bn as health assistance to Zimbabwe over the last twenty years.
A medical body in Zimbabwe has appealed for further talks to reach a agreement acceptable to all parties so the nation's critical HIV programme can be sustained.
Wider Implications
This rejection comes after a comparable case in Kenya, where a high court suspended a similar deal with the US after concerns were raised about the safety of citizens' medical information.
After resuming the presidency recently, US President Donald Trump has slashed overseas assistance and shut down the US Agency for International Development (USAID).
The agency had overseen assistance for the American government, but Trump claimed its spending was "inefficient" and his administration was seeking direct bilateral deals to boost openness and accountability.
As per statements, 16 nations in Africa have so far signed similar health pacts, constituting more than $18.3bn of fresh investment.
Details of the Rejected Agreement
The money for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"We are confident this cooperation could have provided immense advantages for Zimbabwean communities, especially the 1.2 million men, women and children currently receiving antiretroviral therapy via US-supported programmes," the Ambassador commented.
However, government spokesperson Nick Mangwana said the proposed deal was "asymmetrical".
"Our nation was requested to share its genetic material and health information indefinitely, with no equivalent guarantee of access to any medical innovations – such as vaccines, diagnostics, or treatments – that might result from that provided information," he stated.
"Put simply, our country would supply the raw materials for scientific discovery without any certainty that the end products would be available to our people if a future disease outbreak emerge."
National Interest and International Frameworks
He also said that the American exit from the global health body and its push of one-on-one deals were undermining structures previously set up via the international health agency.
Mangwana gave as an example its Pandemic Benefit-Sharing framework designed to deal with potential global health emergencies.
"This mechanism is designed to ensure that when a nation provides its information, the benefits – including vaccines and treatments – are shared equitably, not monopolised exclusively by those with the resources to develop them."
Zimbabwe's reservations over the US deal "must not be interpreted as hostility towards the US," he added.
"We welcome ongoing dialogue with our US partners on how future collaboration could be arranged in a way that respects the sovereignty and interests of each country."
Medical Community Response
A leading public health body stated it recognised the government's concerns, but urged that talks need to persist given that much of the nation's Aids initiatives were funded by international support.
"In cases where specific concerns arise, such as those relating to information security or agreement terms, these can often be resolved via detailed discussion and negotiated safeguards," the group commented.
This impasse underscores the continuing challenges between accepting much-needed foreign assistance and safeguarding a country's data in an increasingly interconnected world.